Search Within

Kimberly Nicole Feigin

  1. "Biostatistics Service"
Formats
  1. Meeting Abstract (11)
  2. Journal Article (4)
Groups
  1. Biostatistics Service (15)
  2. Body Imaging Service (15)
  3. Breast Imaging Service (15)
  4. Breast Medicine Service (15)
  5. Department of Medicine (15)
  6. Epidemiology and Biostatistics (15)

More Groups

People
  1. Sujata Patil (14)
  2. Tiffany Traina (14)
  3. Clifford Hudis (13)
  4. Maria Theodoulou-Haber (10)
  5. Larry Norton (9)
  6. Ayca Gucalp (5)

More People

Years
  1. 2020 (1)
  2. 2018 (1)
  3. 2013 (1)
  4. 2012 (2)
  5. 2011 (2)
  6. 2010 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (4)
  3. Breast Cancer Research and Treatment (2)
  4. Annals of Oncology (1)
  5. Cancer (1)
  6. Clinical Cancer Research (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (5)
  3. Springer (2)
  4. Oxford University Press (1)
  5. Wiley Blackwell (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of bicalutamide in combination with palbociclib for the treatment of androgen receptor (+) metastatic breast cancer
    Meeting Abstract

    Gucalp, A.; Boyle, L. A.; Alano, T.; Arumov, A.; Gounder, M. M.; Patil, S.; Feigin, K.; Edelweiss, M.; D'Andrea, G.; Bromberg, J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase I/II trial of palbociclib in combination with bicalutamide for the treatment of androgen receptor (AR)+ metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Edelweiss, M.; Patil, S.; Gounder, M. M.; Feigin, K. N.; Corben, A.; Arumov, A.; Traina, T. A.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic breast cancer
    Journal Article

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Clinical Cancer Research (2013)

    Fulltext@MSK | Save
  • Endocrine biomarkers in response to AR-inhibition with bicalutamide for the treatment of AR(+), ER/PR(-) metastatic breast cancer (MBC) (TBCRC011)
    Meeting Abstract

    Gucalp, A.; Tolaney, S.; Isakoff, S. J.; Ingle, J.; Liu, M. C.; Carey, L.; Blackwell, K. L.; Rugo, H.; Nabell, L.; Forero, A.; more...
    Cancer Research (2012)

    Fulltext@MSK | Save
  • Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer
    Journal Article

    Gajria, D.; Gonzalez, J.; Feigin, K.; Patil, S.; Chen, C.; Theodoulou, M.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; more...
    Breast Cancer Research and Treatment (2012)

    Fulltext@MSK | Save
  • TBCRC 011: Targeting the androgen receptor (AR) for the treatment of AR+/ER-/PR-metastatic breast cancer (MBC)
    Meeting Abstract

    Gucalp, A.; Tolaney, S. M.; Isakoff, S. J.; Ingle, J. N.; Liu, M. C.; Carey, L. A.; Blackwell, K. L.; Rugo, H. S.; Nabell, L.; Abbruzzi, A.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer
    Journal Article

    Gajria, D.; Feigin, K.; Tan, L. K.; Patil, S.; Geneus, S.; Theodoulou, M.; Norton, L.; Hudis, C. A.; Traina, T. A.
    Cancer (2011)

    Fulltext@MSK | Save
  • A novel capecitabine schedule (7 on—7 off) is feasible with lapatinib for patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Gajria, D.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Drullinsky, P.; D'Andrea, G.; Lake, D.; Norton, L.; Hudis, C.; more...
    Cancer Research (2010)

    Fulltext@MSK | Save
  • Safety of a novel capecitabine dosing schedule when combined with lapatinib in patients with HER2-positive metastatic breast cancer refractory to trastuzumab
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Feigin, K.; Patil, S.; Geneus, S.; Modi, S.; Fornier, M.; Lake, D.; Norton, L.; Hudis, C.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • A novel capecitabine dosing schedule combined with bevacizumab is safe and active in patients with metastatic breast cancer: A phase II study
    Meeting Abstract

    Traina, T. A.; Theodoulou, M.; Dugan, U.; Feigin, K.; Patil, S.; Geneus, S.; Godfrey, L.; Norton, L.; Hudis, C.
    Cancer Research (2009)

    Fulltext@MSK | Save